Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319603049> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- W4319603049 abstract "Over half the world’s cancers occur in Low-and-Middle-Income-Countries (LMICs), where cancer is a neglected disease. Despite significant advances in systemic anticancer therapy, many of these treatments are simple not available to the majority of the world’s cancer patients. For example, immunotherapy has changed the treatment paradigm for many cancer patients in developed countries, significantly prolonging survival and maintaining patient quality of life but at a cost that is currently unaffordable for many public health systems and patients in LMICs. We urgently need better solutions to treat patients more effectively, humanely and equitably. Drug discovery and novel drug development takes on average 10-15 years to go from bench to bedside at an average cost of USD1 billion. Repurposing of 'old' drugs for new indications can shorten this pathway substantially with significant cost savings. One strong drug repurposing candidate is artesunate, an antimalarial derived from traditional Chinese medicine that also displays anticancer properties. This drug is currently the subject of our drug repurposing programme which includes a number of cancers relevant to Malaysian needs including colorectal cancer, cervical cancer, nasopharyngeal cancer and Acute Myeloid Leukaemia. Alongside drug repurposing, platform technologies such as molecular pharming – using plants to grow cancer drugs, in particular immunotherapies and targeted monoclonal antibodies can also reduce the cost of cancer drug development significantly. Malaysia has the opportunity to lead on healthcare priorities facing LMICs, creating reverse linkage collaborations between Muslim countries through entities such as the Islamic Development Bank (which now has a Center of Excellence for Science, Technology and Innovation) in Kuala Lumpur and local governments. This also represents opportunities for technology transfer and halal sector manufacturing. Collaboration is urgently needed between academia, clinicians, patient advocate groups, governments, non-governmental stakeholders, regulators and responsible pharma to ensure equitable access to affordable cancer therapeutics for patients globally." @default.
- W4319603049 created "2023-02-09" @default.
- W4319603049 date "2022-12-24" @default.
- W4319603049 modified "2023-09-30" @default.
- W4319603049 title "Developing Affordable Cancer Therapeutics in Low and Middle Income Countries" @default.
- W4319603049 doi "https://doi.org/10.25163/angiotherapy.637c" @default.
- W4319603049 hasPublicationYear "2022" @default.
- W4319603049 type Work @default.
- W4319603049 citedByCount "0" @default.
- W4319603049 crossrefType "journal-article" @default.
- W4319603049 hasBestOaLocation W43196030491 @default.
- W4319603049 hasConcept C103637391 @default.
- W4319603049 hasConcept C121608353 @default.
- W4319603049 hasConcept C126322002 @default.
- W4319603049 hasConcept C18903297 @default.
- W4319603049 hasConcept C2780035454 @default.
- W4319603049 hasConcept C519536355 @default.
- W4319603049 hasConcept C71924100 @default.
- W4319603049 hasConcept C86803240 @default.
- W4319603049 hasConcept C98274493 @default.
- W4319603049 hasConceptScore W4319603049C103637391 @default.
- W4319603049 hasConceptScore W4319603049C121608353 @default.
- W4319603049 hasConceptScore W4319603049C126322002 @default.
- W4319603049 hasConceptScore W4319603049C18903297 @default.
- W4319603049 hasConceptScore W4319603049C2780035454 @default.
- W4319603049 hasConceptScore W4319603049C519536355 @default.
- W4319603049 hasConceptScore W4319603049C71924100 @default.
- W4319603049 hasConceptScore W4319603049C86803240 @default.
- W4319603049 hasConceptScore W4319603049C98274493 @default.
- W4319603049 hasIssue "3" @default.
- W4319603049 hasLocation W43196030491 @default.
- W4319603049 hasOpenAccess W4319603049 @default.
- W4319603049 hasPrimaryLocation W43196030491 @default.
- W4319603049 hasRelatedWork W3050951227 @default.
- W4319603049 hasRelatedWork W3137715854 @default.
- W4319603049 hasRelatedWork W3159848998 @default.
- W4319603049 hasRelatedWork W4205275007 @default.
- W4319603049 hasRelatedWork W4224322440 @default.
- W4319603049 hasRelatedWork W4225380062 @default.
- W4319603049 hasRelatedWork W4283755545 @default.
- W4319603049 hasRelatedWork W4310838044 @default.
- W4319603049 hasRelatedWork W4366833264 @default.
- W4319603049 hasRelatedWork W3099438243 @default.
- W4319603049 hasVolume "6" @default.
- W4319603049 isParatext "false" @default.
- W4319603049 isRetracted "false" @default.
- W4319603049 workType "article" @default.